Roche

CINtec® Histology is a pioneering brand in the realm of cervical cancer diagnostics, specializing in innovative immunohistochemistry tests. It is the only 510(k) p16 biomarker assay approved for clinical and in vitro diagnostic use, facilitating the evaluation of cervical biopsy specimens with unprecedented accuracy. By enhancing diagnostic objectivity, CINtec® Histology empowers pathologists to identify cervical intraepithelial neoplasia (CIN) with greater consistency and reliability, ultimately improving patient outcomes.

Their flagship product delivers a crucial advantage in diagnosing cervical pre-cancerous lesions, with studies showing significant increases in diagnostic sensitivity and specificity when used in conjunction with traditional methods. The brand ensures that patients receive the most accurate diagnoses to avoid unnecessary treatments. In addition to their testing solutions, CINtec® Histology provides a range of supporting resources, including training modules for pathologists and cytotechnicians, enhancing the overall quality of cervical cancer care. With a commitment to innovation, CINtec® Histology continues to lead advancements within the diagnostic landscape.